Proteomics

Dataset Information

0

Coronary alarmins as residual risk markers of atherosclerosis under hypolipidemic therapy


ABSTRACT: Increased levels of low-density lipoproteins are the main risk factor in the initiation and progression of atherosclerosis. Although statin treatment can effectively lower these levels, there is still a residual risk of cardiovascular events. A more recent therapy, with encouraging results, to regulate the low-density lipoproteins levels, has been represented by the proprotein convertase subtilisin/kexin type 9 inhibition, a protein with critical role in lipid metabolism.Alarmins are endogenous danger signals that are released or secreted from damaged or dead/dying cells as a result of various insults. These stress-sensing molecules have been correlated with various inflammatory states or diseases. We hypothesize that a specific panel of alarmins could indicate the persistence of silent atherosclerosis residual risk.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Oryctolagus Cuniculus (rabbit)

TISSUE(S): Fibroblast

DISEASE(S): Cardiovascular System Disease

SUBMITTER: Felicia Antohe  

LAB HEAD: Felicia Antohe

PROVIDER: PXD035692 | Pride | 2022-10-03

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Miocard_ERA_CVD_9_11_2020.msf Msf
Miocard_ERA_CVD_9_11_2020.mzML Mzml
Miocard_ERA_CVD_9_11_2020.pdResult Other
Miocard_ERA_CVD_Ae_24_1_201026083200.raw Raw
Miocard_ERA_CVD_Ae_24_2_201026103101.raw Raw
Items per page:
1 - 5 of 72

Similar Datasets

2009-08-15 | GSE17647 | GEO
2024-02-05 | GSE254971 | GEO
2024-02-05 | GSE254879 | GEO
2022-02-22 | PXD026379 | Pride
2012-01-19 | GSE35182 | GEO
2006-08-04 | GSE3059 | GEO
2008-12-18 | GSE13985 | GEO
2011-01-14 | GSE26630 | GEO
2011-04-03 | E-GEOD-25425 | biostudies-arrayexpress
2012-01-19 | E-GEOD-35182 | biostudies-arrayexpress